Table 2.
Vaccine Type | RCT Phase | Number Studies | Efficacy (%) | 95% CI (%) | Included Case N | Heterogeneity Test, p-Value | |
---|---|---|---|---|---|---|---|
Lower Limit | Upper Limit | ||||||
Adenovirus-based | 2/3 | 4 | 80.2 | 0.564 | 0.927 | 20771 | <0.001 |
mRNA-based | 2/3 | 2 | 94.6 | 0.936 | 0.954 | 34041 | <0.001 |
RCT = randomized control trial.